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Abstract
Live attenuated vaccines are used to combat tropical theileriosis in North Africa, the Middle East, India, and China. The
attenuation process is empirical and occurs only after many months, sometimes years, of in vitro culture of virulent clinical
isolates. During this extensive culturing, attenuated lines lose their vaccine potential. To circumvent this we engineered the
rapid ablation of the host cell transcription factor c-Jun, and within only 3 weeks the line engineered for loss of c-Jun
activation displayed in vitro correlates of attenuation such as loss of adhesion, reduced MMP9 gelatinase activity, and
diminished capacity to traverse Matrigel. Specific ablation of a single infected host cell virulence trait (c-Jun) induced a
complete failure of Theileria annulata–transformed macrophages to disseminate, whereas virulent macrophages
disseminated to the kidneys, spleen, and lungs of Rag2/cC mice. Thus, in this heterologous mouse model loss of c-Jun
expression led to ablation of dissemination of T. annulata–infected and transformed macrophages. The generation of
Theileria-infected macrophages genetically engineered for ablation of a specific host cell virulence trait now makes possible
experimental vaccination of calves to address how loss of macrophage dissemination impacts the disease pathology of
tropical theileriosis.
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Introduction
Tropical theileriosis caused by Theileria annulata is a major
parasitic disease of cattle and is endemic in North Africa, the
Mediterranean basin and Asia (India and China). Attenuated live
vaccines against tropical theileriosis have been used with success in
endemic countries, in spite of MHC differences between the
different live vaccines and vaccinated animals [1]. One of the
earliest molecular events associated with attenuation of infected
macrophages was loss in Activator Protein-1 (AP-1)-driven mmp9
expression [2,3]. Concomitant with attenuation there is an
alteration in the composition of the different AP-1 family members
binding to the mmp9 promoter [4]. AP-1 is a mixture of dimers
made up of members of the Jun family (c-Jun, JunB, and JunD),
associated with proteins of the Fos (c-Fos, FosB, Fra1, and Fra2),
and ATF2 families [5]. Thus, the outcome of AP-1 activation
results from combinatorial interactions between different family
members binding to the promoters of AP-1-target genes. C-Jun N-
terminal Kinase (JNK) and ATF2 are constitutively activated in
both T. annulata and T. parva infected leukocytes [6,7,8,9].
Constitutive JNK activation promotes survival, proliferation and
metastasis of Theileria-infected leukocytes [10,11,12] indicating
that JNK is a major player in Theileria-induced transformed
leukocyte virulence via its phosphorylation of c-Jun at residues
Ser63 and Ser73 that increases AP-1 transactivation [12].
Matrix Metallo Proteinases (MMPs) and their inhibitors
(TIMPs) play significant roles in immunity, inflammation and
cancer, for reviews see [13]. A disintegrin and metalloproteinases
(ADAMs) are a family of proteins with similarity to snake venom
reprolysins, with a metalloproteinase domain present in MMPs.
Due to their roles in cell adhesion, migration and membrane
protein shedding ADAM expression is often aberrant in tumours,
for review [14]. Of particular relevance to Theileria-transformed
macrophages, where secreted TNF [15] has recently been shown
to play an important role infected macrophage motility [16],
ADAM19 can function as a TNF ‘‘sheddase’’ releasing membrane
bound TNF into the circulation [17,18]. In spite of its established
role as a TNF sheddase and its deregulation in tumour cell lines
ADAM19 expression by Theileria-infected leukocytes has not yet
been described.
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No engineered vaccine exists against tropical theileriosis and so
we describe here the first engineered attenuated T. annulata-
infected line via functional inactivation of a host macrophage
transcription factor (c-Jun) that we have previously shown
mediates T. parva-infected B cell metastasis [12]. By rapidly
targeting a host cell function we have generated an attenuated
macrophage line displaying many of the ablated virulence
phenotypes in just 3 weeks, rather than the circa 2 years of
continuous culture typical of live attenuated vaccines to tropical
theileriosis.
Materials and Methods
Theileria annulata–infected cell lines
Characterisation of the Jed 4 line first isolated in Tunisia has
been reported [19] and in this study virulent (early-passage) Jed 4
corresponds to passage 18. V-Delta 169 is a pool of Jed 4 cells,
which were generated by retroviral transduction of Delta 169-c-
Jun [12] that over-expression of truncated c-Jun lacking the first
169 amino acids ablates c-Jun-mediated transcription, by seques-
tering into inactive complexes endogenous c-Jun and c-Jun
binding partners [20].
The retroviral transduction introduces the vector into 80% of
target cells and we performed 2 successive rounds of transduction
and moreover, the vector encodes resistance to G418 and all
transduced macrophages were drug-resistant. 100% of cells in the
line therefore, expressed the dominant negative c-Jun construct
that is stably integrated into the macrophage genome.
All cultures were maintained at 37uC with 5% CO2 in RPMI-
1640 medium supplemented with 10% Foetal Bovine Serum
(FBS). Cultures were passaged 24 h before harvesting to maintain
the cells in an exponential growth phase.
V: Jed4p18= virulent line
V-Delta 169= engineered attenuated line
Transient transfection experiments and luciferase assays
Transient transfection experiments were carried out using a
3*TRE (Tissue Responsive Element) coll-luciferase reporter
plasmid (2 mg; [9], pGL2luc basic (2 mg), as per [9]. Cytomeg-
alovirus-driven b-galactosidase-expressing vector (500 ng) was
included in each sample for standardization of transfection
efficiency. For luciferase assays, cells were harvested 48 h after
transfection and luciferase activity was assayed in a microplate
luminometer (Berthold technologies, Centro LB960) using a
luciferase assay reagent (Dual-Light Chemiluminescent Reporter
Gene Assay System for the combined detection of luciferase and
b-galactosidase, Applied Biosystems). Luciferase activity was
compared with the basal levels obtained for pGL2-transfected
cells.
Western blot analysis
Cells were harvested and extracted with lysis buffer (Hepes
20 mM, pH 8; NaCl 150 mM; EDTA 2 mM; Nonidet P40 1%;
SDS 0.1%; sodium deoxycholate 0.5% containing protease
inhibitors (Complete mini EDTA free, Roche) and phosphatase
(PhosSTOP, Roche). Lysates were centrifuged at 13,000 rpm
for 15 min at 4uC, and supernatants collected. Equal amounts
of protein were separated by SDS-PAGE, transferred to
nitrocellulose membrane (Protran, Whatman) at 30 V over-
night at 4uC and blocked with 4% skimmed milk for 2 h. The
antibodies used in immunoblotting were as follows: Anti-
pATF2 (pThr71) (sc-7982-R, Santa Cruz Biotechnology, Santa
Cruz, CA); anti-ATF2 (sc-6233, Santa Cruz Biotechnology,
Santa Cruz, CA); anti-c-Jun (sc1694, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA); anti-MMP9 (AV33090; Sigma); anti-
ADAM19 (ARP49780_P050. Aviva Systems Biology); anti-
Actin (I 19-sc1616, Santa Cruz Biotechnology, Santa Cruz,
CA).
Total RNA extraction
Total RNA was isolated from T. annulata-infected Jed 4
macrophages using the RNeasy mini kit (Qiagen) according to the
manufacturer’s instructions. The quality and quantity of the RNA
was determined using a Nanodrop spectrophotometer and gel
electrophoresis. mRNA was reverse transcribed to first-strand
cDNA and the relative level of each transcript was quantified by
real-time PCR using SYBR Green detection. The detection of a
single product was verified by dissociation curve analysis and
relative quantities of mRNA calculated using the method
described by [21]. Relative amount of hprt1 was used to normalise
mRNA levels. Primer sequences used are as follows: ICAM-1:
Forward 59-GCAACTTCTCCTGCTCTGCT-39, Reverse 59- C-
TCCAGGGTCTGGGTTTTGT-39; CD49: Forward 59- AG-
CCCCTCAACATGAACAGA-39, Reverse 59- TCCCACGAG-
TAGGTCTGAGA-39; ITGB5: Forward 59- TGGAACTTGGC-
GAACTCTCT-39, Reverse 59- GGGTTTGCACTTCTGGT-
CAT-39; CD69: Forward 59- AATGGTCAAATGGCCAAGAA-
39, Reverse 59- TCTCAGACCCCGTAAGGTTG-39; TIMP3:
Forward 59- ACAGGCCGAGTCTATGATGG-39, Reverse 59-
ACAGCCCAGGTGATATCGATAGTT-39; ADAM19: For-
ward 59- GGAAGGACATGAATGGGAAA-39, Reverse 59- C-
TCGGAACTCTGACACTGGA-39; MMP9: Forward-59 CCCA-
TTAGCACGCACGACAT-39, Reverse 59- TCACGTAGCC-
CACATAGTCCA-39; HRPT1: Forward-59 TGGACAGGACC-
GAACGGCT-39, Reverse 59- TAATCCAACAGGTCGGCA-
AAG-39.
Author Summary
Tropical theileriosis is a leukaemia-like disease of cattle
caused by the Apicomplexa parasite Theileria annulata.
Live attenuated vaccines are used to control the mortality
and morbidity of tropical theileriosis and each endemic
country produces its own vaccine by isolating a virulent
clinical isolate and then growing the infected and
transformed macrophages for many months in the
laboratory. With time, virulence is progressively lost, and
loss is evaluated from time to time by injecting infected
macrophages into calves and monitoring any resulting
pathology. If the calves demonstrate clinical symptoms, in
vitro culture of vaccine lines continues, and eventually
attenuation is achieved after approximately two years. The
process is empirical, and with time in culture the infected
macrophage lines lose their vaccine potential such that
when cattle are injected the immune response to the
vaccine can be compromised. To circumvent these
problems we engineered the rapid loss of a host
macrophage virulence trait and obtained complete atten-
uation of dissemination of T. annulata–transformed mac-
rophages when tested in an immune-compromised mouse
model. This rational, rather than empirical, approach now
allows injecting into calves Theileria-infected macrophages
engineered for attenuation to evaluate the role of
Theileria-infected macrophage dissemination in the pa-
thology of tropical theileriosis.
Engineered Attenuation
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Adhesion assay
A 96-well plate was coated with bovine fibronectin (Sigma
#F1141), 2 mg/cm2 diluted in double distilled water overnight at
4uC. Then washed twice with 100 mL 0.1% BSA in
RPMI-1640 and blocked for 1 h at 37uC by 0.5% BSA
dissolved in RPMI-1640. After two washes, 16104 cells were
added to each well and incubated at 37uC, 5% CO2 for 30 min.
Non-adherent cells were removed by washing the wells three times
before fixing with 100 mL 4% paraformaldehyde for 10 min at
room temperature (RT). Following one further wash, wells were
stained with 100 mL of crystal violet (1 mg/ml) for 10 min at RT.
Wells were extensively washed with distilled water and air-dried.
Samples were re-suspended by 30 min incubation at RT in
100 mL 2% SDS, 2% ethanol before reading the optical density at
595 nm.
In vitro invasion assays
The invasive capacity of Jed 4 macrophages was assessed in
vitro using matrigel migration chambers and the culture coat 96-
well medium BME cell invasion assay kit (Culturex Instructions,
3482-096-K). After 24 h of incubation at 37uC each well of the
upper chamber was washed once in buffer. The top chamber was
placed on the receiver-plate. 100 mL of cell dissociation solution/
Calcein AM were added to the bottom chamber of each well,
incubated at 37uC for 1 h to fluorescently label cells and dissociate
them from the membrane, before 485 nm excitation and reading
the 520 nm emission using the same parameters as the standard
curve.
Zymography
The identification of MMP9 proteinase activity was performed
using gelatin zymography by electrophoresis of serum-free
conditioned medium collected from confluent cells. 10 ml of
medium were loaded under non-denaturing conditions onto
polyacrylamide zymogram gels supplemented with 0.1% gelatin
to detect the presence of MMP9. Electrophoresis was performed at
a constant voltage of 125 V for 90 min in 16Tris-Glycine SDS.
Gels were washed in renaturing buffer and placed overnight in
incubation buffer, stained with Coomassie brilliant blue R-250
(Sigma, Poole, Dorset, U.K.) and destained with gel-clear destain
solution (250 mg Coomassie Brilliant Blue G-250 (Sigma B-1131)+
125 mL methanol +50 ml glacial acetic acid +350 ml double-
distilled H2O). Normally, areas of gelatin degradation appear as
transparent bands on the blue background, but for imagery the
contrast was inverted to give a black band on a clear background.
A set of wide range molecular mass marker (Sigma) was used to
estimate molecular mass.
Dissemination of transformed Jed4 macrophages in vivo
The attenuated line, V-Delta 169 and virulent line (V: Jed4p18)
macrophages were washed in PBS and injected subcutaneous
(16106 in 0.2 mL of PBS) into Rag2/cC mice [22]. Three
independent experiments were performed, such that each infected
macrophage type was injected into a total of 36 mice. Each group
of 18 mice contained 8 females and 10 males that were sacrificed
and organs examined 12 weeks after injection. For detection of
disseminated T. annulata-transformed Jed 4 macrophages,
kidneys, spleens and lungs were dissected.
Ethics statement
A detailed protocol (number 12–26) entitled ‘‘A recombinant
vaccine against bovine tropical theileriosis caused by Theileria
annulata’’ describing the proposed mice experiments was
submitted to and approved (number CEEA34.GL.03312) by the
ethics committee for animal experimentation at the University of
Paris-Descartes. The university ethics committee is registered with the
French National Ethics Committee for Animal Experimentation that
itself is registered with the European Ethics Committee for Animal
Experimentation. The right to perform the mice experiments was
obtained from the French National Service for the Protection of
Animal Health and satisfied the animal welfare conditions defined by
laws (R214-87 to R214-122 and R215-10) and GL was responsible
for all experiment as he holds the French National Animal
Experimentation permit with the authorisation number (B-75-1249).
DNA preparation and PCR amplification of micro-satellite
loci
The micro-satellite loci have been described [23], DNA of
kidneys, spleens and lungs was purified using a Qiagen QIAamp
DNA Mini Kit according to the manufacturer’s instructions.
Primers were designed to the unique sequence flanking a subset of
repeat loci and used to amplify DNA for parasite detection and
allele size polymorphism.
Ts4: forward 59-ATACTGGAGAGTAAGCTAAC-39
Ts4: reverse 59CAAGGCCATTCAACTTGACATC-39
Ts6: forward 59-CATCCTTTGACCTACTGATTGTAC-39
Ts6: reverse 59-CGGTAGTACCAGTTAATACTGTC-39
Ts8: forward 59-TAAACGATTAAAATCAAGTG-39
Ts8: reverse 59-ATTGGAAATGGTGAAATAATGAG-39
Ts25: forward 59-CGCCATCAGTAGTCATCTCAG-39
Ts25: reverse 59-GACGACCATAACTGGGAAGTCAAC-39
DNA preparations from each stock were PCR amplified in a total
reaction volume of 50 mL under conditions described previously
[24] using the following thermocycler conditions: 94uC for 2 min,
30 cycles of 94uC for 50 s, 50–60uC for 50 s and 65uC for 1 min
with a final extension period of 5 min at 65uC. The amplicons were
separated on a 2% agarose gels and stained with ethidium bromide.
Gels were photographed under ultra-violet transillumination and
the size of each PCR product determined by reference to a 200 bp
DNA ladder (Eurogentec, MW 1700-02).
Results
Suppression of c-Jun leads to down-regulation of AP-1
activity
A Flag-tagged dominant-negative mutant of c-Jun, lacking the
first 169 amino acid transactivation domain (Flag-D169, [25]) was
introduced into T. annulata-infected macrophages (Figure 1A).
AP-1-driven transcription was estimated by co-transfecting a
luciferase reporter gene, whose expression is driven by three copies
of the AP-1 binding element [26]. Over-expression of Flag-D169-
c-Jun reduces by 20-fold AP-1-driven luciferase activity in the
engineered line (V-Delta 169) compared to the virulent Jed 4
macrophage cell line (V: Jed4p18) that harbours vector only
(Fig. 1B). Furthermore, western blot analysis of two AP-1 family
members in the virulent and engineered lines showed that the
expression of c-Jun and the phosphorylation of ATF2 were
decreased (Fig. 1C). The decrease in expression of c-Jun and
ATF2 phosphorylation was quantified using Image J (Fig. 1C1
and C2). We have previously shown that ectopic expression of
Flag-D169-c-Jun in B cells infected with T. parva also induces
down-regulation of c-Jun [12] and now, we observe that in
contrast it induces upregulation in ATF2 protein levels, while
phosphorylation of Thr71 in ATF2 is greatly reduced. The down-
regulation in phosphorylation of ATF2 is therefore, not due to a
decrease in protein levels, but due to Flag-D169-c-Jun mediated
ablation of Thr71 phosphorylation, likely through reduced
Engineered Attenuation
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transcription of a Thr71-specific kinase. Thus, ectopic expression
of D169-c-Jun reduces the levels of c-Jun, an established c-Jun
target gene [27], without noticeably affecting the proliferation of
different types (B cells [12] and macrophages, data not shown) of
Theileria-transformed leukocytes.
Role of c-Jun in transformed Jed 4 macrophage adhesion
to fibronectin
Live attenuated vaccine lines lose adhesion [26,28], and mmp9
expression concomitant with loss of AP-1-activity [4]. Therefore,
we examined the expression levels of a selection of AP-1-target
genes e.g. Cd69 [29], Icam-1 [30], Cd49 [31] and Itgb5 [32]. The
expression levels of these genes were significantly reduced in the
engineered attenuated line V-Delta 169, and adhesion to fibronec-
tin was 4-fold less than virulent (V: Jed4p18) control line (Figure 2).
Significantly, ectopic expression of Flag-D169-c-Jun rapidly (within
3 weeks) dampened expression of Cd69, Icam-1, Cd49 and Itgb5,
whereas it took 3-years of continuous culture (.100 pages) of the
Ode vaccine line to achieve a similar attenuated phenotype [28].
Inhibition of c-Jun results in reduced Matrigel traversal of
the engineered attenuated line
Upregulation of MMPs and reduced expression of their
endogenous inhibitors TIMPs, by promoting cell migration and
Figure 1. Suppression of c-Jun leads to down-regulation of AP-1 activity. A, Flag-tagged dominant-negative mutant of c-Jun, lacking the
first 169 amino acid transactivation domain (Flag-D169) was introduced into T. annulata-infected macrophages. B, Suppression of c-Jun reduces AP-1
activity in T. annulata-infected macrophages, as measured by 3XTRE-driven luciferase activity (TRE-luc). The activity of AP-1 is 20 times lower in the
vaccine line (V-Delta 169) compared to the control line (V). C, Western blot analysis of the expression of two different AP-1 family members in vaccine
and control lines showing that expression of c-Jun is decreased and ATF2 increased in vaccine line. In spite of an increase in ATF2 protein the level of
phospho-ATF2 (p-ATF2) is markedly reduced. Protein amounts were compared to actin and decreases in p-ATF2 and c-Jun quantified using Image J
(C1 and C2).
doi:10.1371/journal.pntd.0003183.g001
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angiogenesis, contribute to tumour progression [33]. ADAM19 is
highly expressed in human primary brain tumours, and expression
and activity are associated with invasiveness [14]. Moreover,
Theileria infection is known to induce AP-1-driven mmp9
expression [2,34] via induction of the methyltransferase SMYD3
that promotes trimethylation of histone H3K4 (H3K4me3) at the
mmp9 promoter [34]. Importantly, concomitant with loss of
virulence MMP9 expression is dampened in the Ode vaccine line
[4]. Our published microarray analyses of the Ode vaccine line
indicated that 13 different mmps, timps 1–4 and 48 adams-related
genes are expressed by T. annulata-infected macrophages [24].
So, we confirmed that mmp9, adam19 and timp3 were expressed
in virulent (V: Jed4p18) macrophages and that ectopic expression
of Flag-D169-c-Jun in the engineered attenuated line altered their
expression (Figure 3). Theileria-infection of Jed 4 macrophages (V:
Jed4p18) induces both adam19 and mmp9 expression and appears
to repress that of timp3. Conversely, ectopic expression of Flag-
D169-c-Jun leads to a dampening of adam19, a reduction in
mmp9, and de-repression of timp3 expression. The protein levels of
MMP9 and ADAM19 reflect alterations in amounts of their
corresponding mRNA (Fig. 3B, left) and for MMP9 this is further
reflected in loss of its gelatinase activity (Fig. 3B, centre).
Consequently, the invasive capacity of the engineered attenuated
line, as determined in Matrigel chamber assays, is significantly
reduced (Fig. 3.D). These in vitro correlates of Theileria-infected
macrophage virulence suggest that the engineered attenuated Jed
4 line would have a reduced capacity to disseminate in vivo.
Dissemination of transformed Jed 4 macrophages in
Rag2/cC mice
It is likely that the reduced dissemination of live attenuated
vaccines, as estimated in heterologous mouse models, allows them
to confer protection of cattle against theileriosis without killing the
vaccinated animal [35]. Moreover, reduced dissemination of live
attenuated vaccines has been ascribed to loss of MMP9 activity
[36]. Above, we showed that the engineered attenuated Jed 4 line
Figure 2. Role of c-Jun-target genes in infected macrophage adhesion to fibronectin. A, Infected macrophage adhesion is downregulated
in the vaccine line (V-Delta 169) compared to virulent (V) Jed 4. RT-qPCR determined levels of genes (cd69, icam-1, cd49 and itgb5) potentially
involved in mediating adhesion. B, Virulent Jed 4 binds at high density to fibronectin compared to the V-Delta 169 vaccine line; 70% of fibronectin
binding capacity is lost upon ablation of c-Jun.
doi:10.1371/journal.pntd.0003183.g002
Engineered Attenuation
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has not only reduced MMP9 activity, increased timp3 levels and
ablated ADAM19 expression compared to control virulent Jed 4
(V: Jed4p18) macrophages, so we tested whether this translated
into a failure to disseminate by their subcutaneous injection into
Rag2/cC mice [12]. Dissemination of virulent Theileria-trans-
formed Jed 4 macrophages (V: Jed4p18) gave rise to metastases in
kidneys, spleen and lungs, and the presence of T. annulata in these
tumours was confirmed by PCR detection of 4 different
microsatellite parasite markers (Ts4, Ts6, Ts8 and Ts25) in tissue
extracts of the 3 different organs and shown in Figure 4 is the
result with Ts4. In contrast, we failed to detect tumours (or
parasite DNA) in the same organs of mice injected with the
engineered attenuated line. Thus, in this heterologous mouse
model for Theileria-transformed macrophage dissemination ec-
topic expression of Flag-D169-c-Jun that diminishes MMP9/
ADAM19 and increases TIMP3 expression led to ablation of
tumour dissemination by the engineered attenuated line.
Discussion
Vaccination trials with recombinant T. annulata antigens have
shown promise, but currently they are not in field use [37,38]. Due
to the emergence of parasite resistance to buparvaquone (Bw720c)
[39] live attenuated vaccines thus remain an important control
measure for tropical theileriosis [40]. However, the immunity
conferred by attenuated vaccines against heterologous challenge
decreases significantly with the time in culture taken to attenuate
them [19]. One reason is the infected macrophage becomes less
immunogenic with the length of time in culture, combined
sometimes with selection of less virulent intracellular parasites
better adapted for growth in vitro [3]. Here, we have attempted to
circumvent the long-term culture via the rapid (3-week) ablation of
c-Jun in virulent Jed 4 (V-Delta 169) infected macrophages.
Injection of the engineered line into Rag2/cC mice demonstrated
it was completely attenuated for dissemination. Parasites were only
detected by PCR amplification of 4 micro-satellites (Ts4, Ts6, Ts8
and Ts25) in 3 different organs of mice injected with virulent Jed4
(V: Jed4p18) and Figure 4 shows the result for the Ts4 locus. Loss
of dissemination could not be ascribed to rapid selection of a less
virulent parasite within V-Delta 169 macrophages. This under-
scores that a key determinant of Theileria-infected macrophage
dissemination is upregulation of c-Jun, rather than stricto senso the
presence of a virulent intracellular parasite.
The long-term culture traditionally required to attenuate
macrophage virulence is believed to sometimes generate either
the selection of an attenuated parasite, or the selection of a less
virulent parasite subpopulation present in the original isolate [3].
In this scenario, if upon vaccination attenuated parasites become
transferred to endogenous macrophages the ensuing infection
would be itself avirulent. Thus, one might have poor immunity
generated by the live attenuated vaccine, but the resulting post-
vaccination ‘‘carrier state’’ would also be attenuated [41]. As
parasites in the rapidly generated V-Delta 169 engineered line
have the same micro-satellite profile as virulent as Jed 4 it implies
that if transferred to endogenous macrophages in vaccinated
animals they could eventually be taken up during a subsequent tick
blood meal with a risk of transfer of virulent parasites to non-
vaccinated animals. Potential transfer of virulent parasites from V-
Delta 169 macrophages to endogenous macrophages can’t be
tested in Rag2/cC mice, as T. annulata only grows in bovine
leukocytes. These studies therefore, will be performed in the future
by experimental vaccination of calves at the National Veterinary
School in Tunisia. Experimental vaccination with macrophages
genetically engineered for ablation of a specific host cell virulence
Figure 3. Inhibition of c-Jun results in reduced metastatic potential in vitro. A, RT-qPCR determination of relative expression shows adam19
and mmp9 are diminished and timp3 levels are augmented in V-Delta 169 macrophages. B, MMP9 and ADAM19 protein levels are also decreased in V-
Delta 169 macrophages. Amounts of actin were used as loading control. C, Gelatin zymography demonstrates that MMP9 proteinase activity is
reduced in supernatants of V-Delta 169 macrophages. D, The invasive capacity, as determined by Boyden chamber assays show that V-Delta 169
macrophages have a 55% reduction in their ability to traverse Matrigel compared to virulent Jed 4 macrophages.
doi:10.1371/journal.pntd.0003183.g003
Engineered Attenuation
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trait should lead to a better appreciation of how transformed
macrophage dissemination contributes to tropical theilriosis
disease pathology.
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